Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis

• Market Cap: ₹65.31B
• Dividend Yield: 0.62%
• Average Volume (3M): 1.77K
• Price to Earnings (P/E): 48.3
• Beta (1Y): 1.12
• Revenue Growth: 3.95%
• EPS Growth: 8.28%
• Country: IN
• Employees: 692
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 8.00
• Shares Outstanding: 51,144,050
• 10 Day Avg. Volume: 1,432
• 30 Day Avg. Volume: 1,768
• PEG Ratio: 1.86
• Price to Book (P/B): 6.14
• Price to Sales (P/S): 5.48
• P/FCF Ratio: 40.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 35.47
• Revenue Forecast (FY): ₹15.75B

• Rating: 61 Neutral
• Price Target: ₹1,424.00 ▼(-9.68% Downside)
• Action: Reiterated Date: 11/07/25
• Date: Action: Reiterated 11/07/25

Alkyl Amines Chemicals Limited's strong financial performance is the primary driver of its overall score, reflecting robust profitability and financial stability. However, technical analysis indicates bearish momentum, and the stock appears overvalued based on its high P/E ratio and low dividend yield. These factors contribute to a moderate overall stock score.

Positive Factors

Strong balance sheet

Low leverage and a strong equity base provide durable financial flexibility. This supports capital expenditure for capacity, cushions cycles in chemical demand, enables strategic M&A or brownfield expansion, and reduces refinancing risk—advantages that sustain competitiveness over months.

Quality cash generation

Consistent operating cash conversion and improved free cash flow underpin self-funded growth and working-capital needs. Reliable cash generation supports reinvestment in specialty product lines, funds maintenance capex, and reduces dependence on external financing over the medium term.

Specialty portfolio & diversified end-markets

A specialty-amine focus with multiple end-markets creates higher entry barriers and recurring demand from qualified industrial customers. Diversified end-market exposure reduces single-market concentration risk and supports steadier revenue streams versus pure commodity chemical players.

Negative Factors

Recent revenue decline

A ~48% year-over-year revenue decline indicates meaningful demand or shipment disruption. Sustained revenue weakness can erode scale economics, pressure margins and cash conversion, and constrain reinvestment capacity unless volumes or pricing recover within the coming quarters.

Margin variability

Fluctuating operating margins signal inconsistent operational leverage and sensitivity to mix or costs. Margin volatility complicates forecasting and capital allocation, making durable profitability less predictable and increasing the risk that short-term shocks persist into medium-term performance.

Feedstock and currency exposure

Dependence on petrochemical-linked feedstocks and export/currency cycles exposes margins to commodity swings and FX moves. Without long-term hedges or pass-through pricing, input and currency volatility can sustainably compress margins and cash flow over several quarters.

Alkyl Amines Chemicals Limited Business Overview & Revenue Model

Company Description

Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. It offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, dimethylaminopropylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. The company also provides special chemicals, such as acetonitrile, 1,8-diazabicyclo[5.4.0]undec-7-ene, alchan 100, alchan 300, 2-aminoethoxy ethanol, 2-ethoxy ethylamine, dimethylpropyleneurea, tetramethyl ethylenediamine, and monomethylamine. It serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. The company was incorporated in 1979 and is headquartered in Navi Mumbai, India.

How the Company Makes Money

Alkyl Amines Chemicals Limited primarily makes money by manufacturing and selling amines and amine-derivative chemical products to industrial customers. Its revenue model is product-sales driven: it produces chemicals at its manufacturing facilities and generates revenue when these products are dispatched to customers in domestic and export markets. Key revenue streams typically include (i) sales of commodity and specialty amines used as intermediates, and (ii) sales of higher-value amine derivatives tailored to specific applications, where differentiation, consistent quality, and long-term customer qualification can support repeat orders. Earnings are influenced by volume growth, product mix (specialty vs. more commoditized products), capacity utilization, and the company’s ability to manage input cost volatility (common feedstocks in amines value chains are petrochemical/commodity-linked), as well as by export demand and currency movements. Specific details on customer concentration, contract structures (spot vs. long-term), pricing formulas, or named strategic partnerships are null.

Alkyl Amines Chemicals Limited Financial Statement Overview

Summary

Alkyl Amines Chemicals Limited demonstrates strong financial health characterized by robust profitability, a solid balance sheet, and reliable cash flow generation. The company exhibits a positive growth trajectory in revenue and profitability, supported by low leverage and effective equity management. While operational efficiency and cash flow variability present risks, the overall financial position remains strong.

Income Statement

The company shows strong profitability with a consistent increase in gross profit and net profit margins over time. The revenue growth rate from 2024 to 2025 is notable, indicating a positive trajectory. However, the EBIT and EBITDA margins have shown fluctuations, indicating potential volatility in operational efficiency.

Balance Sheet

The balance sheet is robust with a low debt-to-equity ratio, indicating low leverage and financial stability. The return on equity is healthy, reflecting effective use of shareholder funds. The equity ratio is strong, highlighting a solid asset base funded by equity.

Cash Flow

Operating cash flow remains strong and consistently aligns well with net income, indicating quality earnings. Free cash flow has improved significantly in recent years, showcasing better capital management. However, historical fluctuations in free cash flow growth rates signal potential variability in cash flow generation.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	15.78B	15.72B	14.41B	16.83B	15.42B	12.42B
Gross Profit	7.12B	7.14B	6.54B	8.04B	6.92B	7.08B
EBITDA	2.91B	2.97B	2.54B	3.48B	3.26B	4.30B
Net Income	1.87B	1.86B	1.49B	2.29B	2.25B	2.95B
Balance Sheet
Total Assets	0.00	17.89B	15.84B	15.90B	13.71B	11.45B
Cash, Cash Equivalents and Short-Term Investments	2.03B	2.03B	303.92M	171.95M	615.33M	1.55B
Total Debt	0.00	55.20M	31.68M	877.50M	232.89M	474.92M
Total Liabilities	-14.02B	3.86B	3.16B	4.21B	3.82B	3.53B
Stockholders Equity	14.02B	14.02B	12.67B	11.69B	9.90B	7.92B
Cash Flow
Free Cash Flow	0.00	2.15B	1.53B	-550.40M	-422.81M	2.08B
Operating Cash Flow	0.00	2.63B	2.75B	2.48B	2.05B	3.64B
Investing Cash Flow	0.00	-1.96B	-1.21B	-2.77B	-2.06B	-2.13B
Financing Cash Flow	0.00	-491.50M	-1.40B	80.00M	-572.89M	-864.51M

Alkyl Amines Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1576.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1576.7 is above the 20-day moving average (MA) of 1414.11, above the 50-day MA of 1508.54, and below the 200-day MA of 1851.04, indicating a bearish trend. The MACD of -72.71 indicates Positive momentum. The RSI at 24.29 is Positive, neither overbought nor oversold. The STOCH value of 17.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.

Alkyl Amines Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GNFC	70 Outperform	₹60.64B	12.10	―	3.68%	-7.53%	42.74%
BALAMINES	69 Neutral	₹32.39B	29.53	―	0.97%	-10.76%	-27.70%
GSFC	68 Neutral	₹62.36B	11.49	―	2.80%	15.25%	26.49%
RALLIS	63 Neutral	₹46.48B	700.00	―	0.92%	0.91%	18.12%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ALKYLAMINE	61 Neutral	₹65.31B	48.28	―	0.62%	3.95%	8.28%
RCF	60 Neutral	₹64.80B	24.87	―	0.93%	-3.19%	59.25%

Alkyl Amines Chemicals Limited Corporate Events

Alkyl Amines Shareholders Approve Revised Remuneration for Whole-time Director via Postal Ballot

Alkyl Amines Chemicals Limited has announced that its shareholders have approved, via postal ballot through remote e-voting, a special resolution to revise the remuneration of Whole-time Director – Operations, Mr. Rakesh S. Goyal, effective from January 1, 2026 until the end of his current term on May 31, 2027. The resolution, in which the promoter and promoter group were not treated as interested parties, was passed with the requisite majority, reinforcing board-endorsed management continuity and compensation structure, and the voting results along with the scrutinizer’s report have been made available on the company’s and NSDL’s websites for stakeholder transparency.